| Serial Number | 79412060 |
| Word Mark | ZYMEWORKS |
| Filing Date | Tuesday, October 15, 2024 |
| Status | 661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED |
| Status Date | Tuesday, December 2, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | NOT AVAILABLE |
| Goods and Services | Chemical, biochemical and biological research and analysis; research and development in the field of biotechnology; medical and pharmacological research services and product development in the field of biologics, proteomics, and antibody engineering; pharmaceutical products development and pharmaceutical product evaluation; scientific research in the nature of conducting clinical trials for others for pharmaceutical products; scientific research and development of preparations, agents and technology for the development of antibody therapeutics for the treatment, and prophylaxis of human diseases, disorders and conditions, namely, cancer, auto immune and inflammatory diseases; providing scientific information to scientists, physicians and health care providers in the fields of cancer, auto immune diseases, inflammatory diseases, and infectious diseases; chemical molecular analysis provided to pharmaceutical, biotechnology and chemical industries using proprietary software and proprietary analytical tools and algorithms; product optimization services, namely, research and development services of new pharmaceutical products provided to pharmaceutical, biotechnology and chemical industries using proprietary software and proprietary analytical tools and algorithms |
| Description of Mark | The mark consists of a zig-zag design made of seven shaded circles connected by lines, all above the stylized wording "zymeworks". |
| Goods and Services | Pharmaceutical preparations for regulating the immune system, antibodies, antibody-drug conjugates, and their constituents; medicines for human purposes for the treatment of cancer, autoimmune and autoinflammatory diseases; diagnostic preparations for medical purposes; chemical preparations for pharmaceutical and medical purposes, namely, the treatment and diagnosis of cancer, autoimmune and autoinflammatory diseases; chemical preparations for pharmaceutical and medical purposes, namely, regulating the immune system, antibodies, antibody-drug conjugates, and their constituents; biological preparations for medical and pharmaceutical purposes, namely, biologic and recombinant therapeutic agents comprised of monoclonal antibodies, multispecific and bispecific antibodies, antibody fragments, antibody-drug conjugates, fusion proteins, recombinant proteins, cytokines, peptides, and nucleic acid-based biologics and their constituents, derivatives, variants, conjugates, and formulations; therapeutic preparations, prophylactic preparations, and pharmaceutical products and agents for the treatment or prophylaxis of cancer; therapeutic preparations, prophylactic preparations, and pharmaceutical products and agents for the treatment or prophylaxis of human autoimmune diseases, disorders and conditions; therapeutic preparations, prophylactic preparations, and pharmaceutical products and agents for the treatment or prophylaxis of human inflammatory diseases, disorders and conditions |
| Pseudo Mark | ENZYME WORKS; N ZYME WORKS |
| Goods and Services | Intellectual property licensing services |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, December 12, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, December 12, 2024 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 045 - Legal services; security services for the protection of property and individuals; personal and social services rendered by others to meet the needs of individuals. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, December 12, 2024 |
| Primary Code | 045 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Zymeworks BC Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | CA |
| Event Date | Event Description |
| Thursday, December 12, 2024 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Friday, December 13, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, December 13, 2024 | APPLICATION FILING RECEIPT MAILED |
| Monday, March 24, 2025 | ASSIGNED TO EXAMINER |
| Monday, March 31, 2025 | NON-FINAL ACTION WRITTEN |
| Tuesday, April 1, 2025 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Tuesday, June 3, 2025 | REFUSAL PROCESSED BY MPU |
| Tuesday, June 3, 2025 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Saturday, June 21, 2025 | REFUSAL PROCESSED BY IB |
| Tuesday, December 2, 2025 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, December 2, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, December 2, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |